Drug Discovery Services Market Forecast, Trends, Opportunities And Growth 2025-2034

Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

What Is the Growth Potential of the Drug Discovery Services Market Size Over 2025-2034?
The drug discovery services market size has grown rapidly in recent years. It will grow from $18.27 billion in 2024 to $20.52 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increased R&D investment, expanding disease burden, government funding and support, emergence of contract research organizations (CROs), shift towards personalized medicine, drug repurposing strategies.

The drug discovery services market size is expected to see rapid growth in the next few years. It will grow to " $34.38 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to regulatory framework changes, advancements in drug delivery systems, increasing interest in immunotherapy, shift towards RNA-based therapeutics, targeting rare diseases. Major trends in the forecast period include advanced technologies adoption, biologicals and biopharmaceuticals growth, adoption of high-throughput screening, advancements in virtual screening, regenerative medicine focus.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8324&type=smp

What Are the Underlying Growth Drivers for the Drug Discovery Services Market?
The growing focus on drug discovery trials is expected to propel the drug discovery services market. The drug development life cycle is critical for ensuring safe and effective drug delivery. Due to this, clinical trials are gaining prominence as an essential component of drug development. With the increasing importance of drug development and innovation in healthcare, the demand for drug discovery trials worldwide has increased. For instance, in May 2023, according to ClinicalTrials.gov, a platform for registering clinical trials, the total number of clinical trials reported 452,604 in 2023 an increase from 365,000 registered trials reported in 2021. Therefore, the growing focus on drug discovery trials will drive the growth of the drug discovery services market.

How Is the Drug Discovery Services Market Categorized Based on Key Segments?
The drug discovery servicesmarket covered in this report is segmented –

1) By Type: Chemistry Services; Biology Services
2) By Process: Target Selection; Target Validation; Hit-To-Lead identification; Lead Optimization; Candidate Validation
3) By Drug Type: Biologics Drug ; Small Molecule Drug
4) By End user: Pharmaceutical And Biotechnology Companies; Academic Institutes; Other End Users

Subsegments:
1) By Chemistry Services: Medicinal Chemistry; Compound Management; High-Throughput Screening; Lead Optimization
2) By Biology Services: In Vitro Studies; In Vivo Studies; Pharmacokinetics And Pharmacodynamics (PK Or PD); Biomarker Discovery

Which Emerging Trends Are Shaping the Future of the Drug Discovery Services Market?
Major companies operating in the drug discovery services market are innovating advanced technologies, such as artificial intelligence (AI) and machine learning (ML), to enhance the efficiency and accuracy of the drug discovery process. Artificial Intelligence (AI) and Machine Learning (ML) are closely related fields within computer science. AI refers to the development of computer systems that can perform tasks typically requiring human intelligence. ML is a subset of AI that focuses on the use of algorithms and statistical models that enable computers to learn from and make predictions or decisions based on data. For instance, in February 2024, Eurofins Discovery, a France-based company, that support services across various sectors, including pharmaceuticals, announced the launch of innovative platform called DiscoveryAI SAFIRE (Suite of ADMET Predictions for In Silico Refinement and Evaluation). This advanced platform utilizes proprietary datasets, artificial intelligence (AI), and machine learning (ML) to enhance the drug discovery process. SAFIRE is designed to expedite the discovery of new pharmaceuticals by predicting the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties of molecules.The platform leverages data from Eurofins Discovery's extensive BioPrint database, which has been meticulously curated over years of research.

Who Are the Key Strategic Players in the Drug Discovery Services Market Ecosystem?
Major companies operating in the drug discovery services market are Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, Domainex Ltd., GenScript Biotech Corporation, Pharmaceutical Product Development LLC, Advinus Therapeutics Pvt. Ltd., Jubilant Biosys Ltd., Evotec AG, Syngene International Ltd., Bayer AG, Merck KGaA, Ubiquigent Ltd., Eurofins Scientific SE, AppTec Laboratory Services Inc., GVK Biosciences Private Limited, Aurigene Discovery Technologies Limited, Viva Biotech Holdings, Pharmaron Beijing Co. Ltd., Selcia Limited, Concept Life Sciences Group Limited, BioDuro LLC, ChemPartner Corporation, Aptuit LLC, Sygnature Discovery Limited, Peak Proteins Ltd., SRI International, BioAscent Discovery Limited, Sai Life Sciences Limited, Promega Corporation, MedChemExpress LLC, Aragen Bioscience Inc., WuXi STA, BioNTech SE, Moderna Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Amgen Inc., Bristol-Myers Squibb Company

Get the detailed drug discovery services market report today
https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

What Are the Fastest-Growing Regions in the Drug Discovery Services Market?
North America was the largest region in the drug discovery services market in 2024. The regions covered in the drug discovery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company